PAPER Brunden KR, Trojanowski JQ, Smith AB 3rd, Lee VM, Ballatore C
SEARCH RESULTS
331007 RESULTS
PAPER Smith PF
Vestibular dysfunction and Alzheimer’s disease.
Med Hypotheses. 2013 Dec;81(6):1169-70. PubMed: 24436971PAPER Araki T, Wake R, Miyaoka T, Kawakami K, Nagahama M, Furuya M, Limoa E, Liaury K, Hashioka S, Murotani K, Horiguchi J
The effects of combine treatment of memantine and donepezil on Alzheimer's Disease patients and its relationship with cerebral blood flow in the prefrontal area.
Int J Geriatr Psychiatry. 2014 Jan 17; PubMed: 24436135PAPER Sanchez-Mut JV, Aso E, Heyn H, Matsuda T, Bock C, Ferrer I, Esteller M
Promoter hypermethylation of the phosphatase DUSP22 mediates PKA-dependent TAU phosphorylation and CREB activation in Alzheimer's disease.
Hippocampus. 2014 Apr;24(4):363-8. Epub 2014 Jan 28 PubMed: 24436131PAPER Itokazu Y, Yu RK
Amyloid β-Peptide 1-42 Modulates the Proliferation of Mouse Neural Stem Cells: Upregulation of Fucosyltransferase IX and Notch Signaling.
Mol Neurobiol. 2014 Jan 17; PubMed: 24436056PAPER Søgaard R, Sørensen J, Waldorff FB, Eckermann A, Buss DV, Phung KT, Waldemar G
Early psychosocial intervention in Alzheimer's disease: cost utility evaluation alongside the Danish Alzheimer's Intervention Study (DAISY).
BMJ Open. 2014 Jan 15;4(1):e004105. PubMed: 24435893PAPER Saint-Aubert L, Nemmi F, Péran P, Barbeau EJ, Payoux P, Chollet F, Pariente J
Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo.
Eur J Nucl Med Mol Imaging. 2014 May;41(5):836-43. Epub 2013 Dec 19 PubMed: 24435769PAPER Kurata T, Lukic V, Kozuki M, Wada D, Miyazaki K, Morimoto N, Ohta Y, Deguchi K, Yamashita T, Hishikawa N, Matsuzono K, Ikeda Y, Kamiya T, Abe K
Long-term Effect of Telmisartan on Alzheimer's Amyloid Genesis in SHR-SR After tMCAO.
Transl Stroke Res. 2014 Jan 17; PubMed: 24435631PAPER Daschil N, Geisler S, Obermair GJ, Humpel C
Short- and long-term treatment of mouse cortical primary astrocytes with β-amyloid differentially regulates the mRNA expression of L-type calcium channels.
Pharmacology. 2014;93(1-2):24-31. Epub 2014 Jan 9 PubMed: 24435206PAPER Ong QR, Chan ES, Lim ML, Cole GM, Wong BS
Reduced phosphorylation of brain insulin receptor substrate and Akt proteins in apolipoprotein-E4 targeted replacement mice.
Sci Rep. 2014 Jan 17;4:3754. PubMed: 24435134PAPER Rajan KB, Wilson RS, Skarupski KA, Mendes de Leon CF, Evans DA
Gene-behavior interaction of depressive symptoms and the apolipoprotein E {varepsilon}4 allele on cognitive decline.
Psychosom Med. 2014 Feb;76(2):101-8. Epub 2014 Jan 16 PubMed: 24434953PAPER Nordberg A
Molecular imaging in sporadic Alzheimer's disease populations and those genetically at risk.
Neurodegener Dis. 2014;13(2-3):160-2. Epub 2014 Jan 9 PubMed: 24434947PAPER Moretti DV, Paternicò D, Binetti G, Zanetti O, Frisoni GB
Electroencephalographic upper/low alpha frequency power ratio relates to cortex thinning in mild cognitive impairment.
Neurodegener Dis. 2014;14(1):18-30. Epub 2014 Jan 8 PubMed: 24434624PAPER Emre M, Poewe W, De Deyn PP, Barone P, Kulisevsky J, Pourcher E, van Laar T, Storch A, Micheli F, Burn D, Durif F, Pahwa R, Callegari F, Tenenbaum N, Strohmaier C
Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study.
Clin Neuropharmacol. 2014 Jan-Feb;37(1):9-16. PubMed: 24434526PAPER Aprahamian I, Stella F, Forlenza OV
New treatment strategies for Alzheimer's disease: is there a hope?
Indian J Med Res. 2013 Oct;138(4):449-60. PubMed: 24434253Current Filters
No filters selected